We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 46

Amendments to the Patented Medicines (Notice of Compliance) Regulations now in force
  • Torys LLP
  • Canada
  • June 13 2008

On June 12, 2008, amendments to the Patented Medicines (Notice of Compliance) Regulations (commonly referred to as the “PM(NOC) Regulations”) came into force


Canadian and U.S. regulation of functional food claims
  • Torys LLP
  • Canada, USA
  • October 12 2010

In today's health-conscious marketplace, functional food labelling has grown into a multibillion dollar industry


Proposed amendment would exempt some generic submissions from Canada’s PM(NOC) regulations
  • Torys LLP
  • Canada
  • October 4 2011

Health Canada has released a proposed amendment to its guidance document Patented Medicines (Notice of Compliance) Regulations


Considerations for medical device software companies entering the Canadian market
  • Torys LLP
  • Canada
  • July 25 2011

Canada has one of the world’s largest medical device markets, estimated at C$6 billion in 2010, with sales of almost C$3 billion taking place in Ontario


Ontario court confirms generic drug manufacturers not entitled to unjust enrichment
  • Torys LLP
  • Canada
  • January 22 2013

On January 15, 2013, the Ontario Superior Court of Justice (Ontario Court) granted a motion for partial summary judgment in Apotex Inc. v. Abbott


Changes in the regulation of energy drinks in Canada
  • Torys LLP
  • Canada
  • October 18 2011

On October 6, 2011, Health Canada announced its decision to begin regulating most energy drinks as foods


Doing a deal with pharma
  • Torys LLP
  • Canada
  • August 4 2011

From the perspective of the biotech company, there are several legal and business issues to consider when doing a deal with big pharma


Proposed amendments to the Patented Medicines (Notice of Compliance) Regulations
  • Torys LLP
  • Canada
  • April 29 2008

On April 26, 2008, the government of Canada published for comment proposed amendments to the Patented Medicines (Notice of Compliance) Regulations, commonly referred to as the “PM(NOC) Regulations.”


Canada proposes amending the Food and Drugs Act and creating consumer product safety legislation
  • Torys LLP
  • Canada
  • May 2 2008

On April 8, 2008, the federal government tabled legislation in the House of Commons to amend the Food and Drugs Act and to introduce new consumer product safety legislation in Canada


Draft guidelines on subsequent entry biologics
  • Torys LLP
  • Canada
  • February 15 2008

Health Canada has released a draft guidance document titled “Information and Submission Requirements for Subsequent Entry Biologics (SEBs).”